Hikma enters settlement agreement with Jazz to sell Xyrem generic
07-04-2017
Hikma launches generic Xeloda in the US
21-07-2016
Igorgolovniov / Shutterstock.com
Hikma Pharmaceuticals has secured a win in its “skinny label” patent suit with Amarin Pharmaceuticals, following a ruling handed down by a federal court in the state of Delaware.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Hikma Pharmaceuticals, Amarin Pharmaceuticals, Vascepa, generics
